Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

At their Annual Meeting 13 Sept, the Trustees of the Royal Society of Tropical Medicine and Hygiene (RSTMH) awarded MORU’s Dr Direk Limmathurotsakul its Emerging Leaders Award.

Awarded annually, the RSTMH Emerging Leaders Award recognises significant contributions in leadership and service, including mentoring and other forms of capacity-building, to the fields of tropical medicine and global health by early-career investigators based in low and middle-income countries.

Based in Bangkok and Head of Microbiology at MORU, Direk is an Assistant Professor at the Faculty of Tropical Medicine at Mahidol University in Thailand and a Wellcome Trust Intermediate Fellow in Public Health and Tropical Medicine.

“I would like to thank my colleagues Susanna Dunachie and Nick Day who nominated me and presented the citation at the meeting. I very much appreciate their kindness and support,” said Direk at the Awards ceremony.

Recognised as a world expert on melioidosis, an infectious disease caused by Burkholderia pseudomallei, Direk has published more than 100 publications on melioidosis over the past decade and led a series of laboratory and clinical studies demonstrating for the first time that ingestion and inhalation are important infection routes for melioidosis in northeast Thailand.

Direk also developed the first evidence-based guidelines for the prevention of melioidosis for people living in endemic areas and recently published a landmark melioidosis paper, estimating the global burden of melioidosis, in Nature Microbiology 2016. He mapped all documented human and animal cases, and the presence of environmental B. pseudomallei, and combined this in a formal modelling to estimate the global burden of melioidosis. He estimated there to be 165,000 human melioidosis cases per year worldwide, of which 89,000 die.

A lead researcher in antimicrobial resistance in Southeast Asia, Direk’s on-going research includes antibiotic use in animals, estimating the burden of antimicrobial-resistant infections in Southeast Asia, and identifying where resources are most needed to fight effectively against antimicrobial resistance in low and middle-income countries.

Similar stories

Tropical Medicine DPhil Students awarded NDM Prize

Every year, the Nuffield Department of Medicine awards NDM Prizes to our most outstanding students. This year, Mo yin and Rebecca Inglis (both at MORU) were highly commended in the category NDM Overall Prize, for conducting research with an outstanding impact. Will Schilling (MORU) received a prize as first year DPhil student, and Mohammad Ali (OCGHR) as second year DPhil student. Our warmest congratulations to you all!

Congratulations new Associate Professors

Following the meeting of the Medical Sciences Divisional Committee to consider applications for the conferral of the title of Associate Professor, we are pleased to announce that Rashan Haniffa, Dorcas Kamuya, Isabella Oyier, Le Van Tan and Timothy Walker have been awarded the title Associate Professor

COPCOV now world’s largest COVID-19 pre-exposure prophylaxis trial

A 6-week recruitment burst at Aga Khan University in Pakistan led the way as COPCOV enrolment broke 1600 participants. Led by MORU, COPCOV is the world’s largest trial trying to determine if hydroxychloroquine and chloroquine prevent COVID-19.

How did people in Europe and SE Asia experience the first COVID-19 wave?

An international team, led by Phaik Yeong Cheah, conducted an anonymous online survey from May-June 2020, asking 5,058 people in Thailand, Malaysia, United Kingdom, Italy and Slovenia to share their experiences. Anne Osterrieder and colleagues report the unequal impacts of public health measures, and the prevalence of ‘fake news’.

Recruitment surges in COPCOV COVID-19 prevention study

As high COVID-19 daily cases and highly transmissible variants risk overwhelming countries’ healthcare systems, COPCOV, the world’s last-standing large prophylaxis RCT, faces tight timelines to determine whether chloroquine/ hydroxychloroquine prevents COVID-19

Simple blood tests may help improve malaria diagnosis in clinical studies

About one-third of children diagnosed with severe malaria may instead have an alternative cause of illness, but simple blood tests could help researchers distinguish between the two and speed up research on new treatments.